Search icon A magnifying glass. It indicates, "Click to perform a search".
Close icon Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification.
Chevron icon It indicates an expandable section or menu, or sometimes previous / next navigation options. HOMEPAGE
Reuters

BRIEF-Sarepta Therapeutics reports FDA clearance of IND for co's ppmo exon 51 candidate, srp-5051

Reuters
2017-11-07T13:52:04Z
Read in app

Nov 7 (Reuters) - Sarepta Therapeutics Inc:

Advertisement

* Sarepta Therapeutics announces FDA clearance of IND for the company's ppmo exon 51 candidate, srp-5051

* Sarepta Therapeutics Inc - will immediately initiate its phase 1/2a clinical trial and begin screening patients with dmd amenable to skipping exon 51​ Source text for Eikon: Further company coverage:

Read the original article on Reuters. Copyright 2017. Follow Reuters on Twitter.

Read next

Advertisement
Close icon Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification.

Jump to

  1. Main content
  2. Search
  3. Account